These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22374421)

  • 1. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.
    Gironés R; Torregrosa D; Gómez-Codina J; Maestu I; Tenias JM; Rosell R
    Clin Transl Oncol; 2012 Mar; 14(3):183-9. PubMed ID: 22374421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desire for Information in the Elderly: Interactions with Patients, Family, and Physicians.
    Gironés R
    J Cancer Educ; 2015 Dec; 30(4):766-73. PubMed ID: 25428838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews.
    Silvestri G; Pritchard R; Welch HG
    BMJ; 1998 Sep; 317(7161):771-5. PubMed ID: 9740561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support.
    Brundage MD; Feldman-Stewart D; Cosby R; Gregg R; Dixon P; Youssef Y; Mackillop WJ
    Patient Educ Couns; 2001 Nov; 45(2):149-57. PubMed ID: 11687329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients preferences in chemotherapy for advanced non-small-cell lung cancer.
    Hirose T; Horichi N; Ohmori T; Kusumoto S; Sugiyama T; Shirai T; Ozawa T; Ohnishi T; Adachi M
    Intern Med; 2005 Feb; 44(2):107-13. PubMed ID: 15750269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
    Pacchiana MV; Capelletto E; Carnio S; Gridelli C; Rossi A; Galetta D; Montagna ES; Bordi P; Ceribelli A; Cortinovis D; Scotti V; Martelli O; Valmadre G; Del Conte A; Miccianza A; Morena R; Rosetti F; Di Maio M; Ostacoli L; Novello S
    Clin Lung Cancer; 2017 Jul; 18(4):381-387. PubMed ID: 27965013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.
    Kehl KL; Landrum MB; Arora NK; Ganz PA; van Ryn M; Mack JW; Keating NL
    JAMA Oncol; 2015 Apr; 1(1):50-8. PubMed ID: 26182303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
    Blinman P; Hughes B; Crombie C; Christmas T; Hudson M; Veillard AS; Muljadi N; Millward M; Wright G; Flynn P; Windsor M; Stockler M; McLachlan SA;
    Eur J Cancer; 2015 Aug; 51(12):1529-37. PubMed ID: 26059196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.
    Moth E; McLachlan SA; Veillard AS; Muljadi N; Hudson M; Stockler MR; Blinman P
    Lung Cancer; 2016 May; 95():8-14. PubMed ID: 27040845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patient-rated performance status affect treatment decisions in advanced lung cancer?
    Dajczman E; Kasymjanova G; Kreisman H; Swinton N; Pepe C; Small D
    J Thorac Oncol; 2008 Oct; 3(10):1133-6. PubMed ID: 18827609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
    Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
    Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-physician communication concerning participation in cancer chemotherapy trials.
    Sørensen JB; Rossel P; Holm S
    Br J Cancer; 2004 Jan; 90(2):328-32. PubMed ID: 14735172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
    Meoni G; Cecere FL; Lucherini E; Di Costanzo F
    J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer.
    Mühlbacher AC; Bethge S
    Eur J Health Econ; 2015 Jul; 16(6):657-70. PubMed ID: 25135768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferred and actual involvement of advanced lung cancer patients and their families in end-of-life decision making: a multicenter study in 13 hospitals in Flanders, Belgium.
    Pardon K; Deschepper R; Vander Stichele R; Bernheim JL; Mortier F; Schallier D; Germonpré P; Galdermans D; Kerckhoven WV; Deliens L;
    J Pain Symptom Manage; 2012 Mar; 43(3):515-26. PubMed ID: 22048004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer.
    Dubey S; Brown RL; Esmond SL; Bowers BJ; Healy JM; Schiller JH
    J Support Oncol; 2005; 3(2):149-54. PubMed ID: 15796447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
    Aggarwal C; Langer CJ
    Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
    Ikeda S; Yoshioka H; Ikeo S; Morita M; Sone N; Niwa T; Nishiyama A; Yokoyama T; Sekine A; Ogura T; Ishida T
    BMC Cancer; 2017 Nov; 17(1):797. PubMed ID: 29183294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic chemotherapy in advanced non-small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice.
    Kancharla H; Gundu N; Pathak N; Vandidassane I; Khurana S; Pushpam D; Jain D; Kumar S; Pathy S; Mohan A; Malik PS
    Curr Probl Cancer; 2020 Jun; 44(3):100550. PubMed ID: 31987521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.